Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Exelixis
Tango Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
AstraZeneca